Bulletin of Experimental Biology and Medicine

, 148:332

The Use of Ultralow Doses of Antibodies to C-Terminal Fragment of Angiotensin II AT1 Receptor (Kardos) in the Therapy of Arterial Hypertension

Authors

  • V. I. Petrov
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • S. V. Nedogoda
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • O. I. Epshtein
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • T. A. Chalyabi
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • U. A. Brel’
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • N. G. Chepurina
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • G. V. Mazina
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • M. V. Kachanova
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • L. V. Sabanov
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • S. A. Tarasov
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • Yu. A. Zabolotneva
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • A. E. Kolosova
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
  • S. A. Sergeeva
    • Volgograd State Medical UniversityFederal Agency for Health Care and Social Development
Ultralow Doses

DOI: 10.1007/s10517-009-0686-9

Cite this article as:
Petrov, V.I., Nedogoda, S.V., Epshtein, O.I. et al. Bull Exp Biol Med (2009) 148: 332. doi:10.1007/s10517-009-0686-9

Kardos monotherapy allows attaining the target levels of systolic and diastolic blood pressure in patients with high-risk and very-high-risk hypertension. We demonstrated excellent tolerability of the preparation in combination with reliable blood pressure decrease over 24 h, during day and night hours.

Key Words

kardosarterial hypertension24-h monitoringultralow doses of antibodies

Copyright information

© Springer Science+Business Media, Inc. 2009